Login
$INVA
$18.49 -$0.54 (2.84%) Live

$INVA 8-K/A SEC Filings

Filed On Filing
28 Oct 2022 8-K/A: Completion of Acquisition or Disposition of Assets

On July 20, 2022, Innoviva TRC Holdings LLC (the “Seller”), a Delaware limited liability company and wholly-owned subsidiary of Innoviva, Inc. (the “Company”), completed the sale (the “Sale”) contemplated by the Equity Purchase Agreement...

04 May 2022 8-K/A: Departure/Election of Directors or Officers; Compensation

This Current Report on From 8-K/A of Innoviva, Inc. (the “Company”) amends the Company’s Current Report on Form 8-K dated April 29, 2022 and filed with the Securities and Exchange Commission on May 2, 2022 (the “Original Filing”) to corr...

21 Jul 2017 8-K/A: Submission of Matters to a Vote of Security Holders

As previously disclosed, at the Annual Meeting, Innoviva’s stockholders cast over a majority of votes in favor of holding future say on pay votes on an annual basis. Innoviva’s board of directors (the “Board”) had recommended a vote for ...

28 Apr 2017 8-K/A: Submission of Matters to a Vote of Security Holders

On April 27, 2017, IVS delivered its final vote tabulation that certified the voting results for each of the matters set forth below that were submitted to a vote at the Annual Meeting.

06 Mar 2014 8-K/A: Entry into a Material Definitive Agreement

This Theravance Strategic Alliance Agreement Amendment (the “Amendment”) is entered into on March 3, 2014 between Theravance, Inc., a Delaware corporation (“Theravance”), and Glaxo Group Limited, a private company limited by shares regis...

02 Dec 2011 8-K/A: Other Events

This communication is a follow up to our initial communication dated November 16, 2011 advising you of an issue that has occurred at the third party manufacturer of VIBATIV. The manufacturer has informed Astellas that they have notified ...

17 Dec 2010 8-K/A: Departure/Election of Directors or Officers; Compensation

(d) Theravance, Inc. (“Theravance”) is filing this amendment to its Current Report on Form 8-K, filed with the Securities and Exchange Commission (the “SEC”) on October 22, 2010, to disclose the appointment of Henrietta Holsman Fore to t...

08 Jun 2010 8-K/A: Submission of Matters to a Vote of Security Holders

(a) The Annual Meeting of Stockholders of Theravance, Inc. was held on April 27, 2010.

01 Feb 2008 8-K/A: Departure/Election of Directors or Officers; Compensation

(d) Theravance, Inc. (Theravance) is filing this amendment to its Current Report on Form 8-K, filed with the Securities and Exchange Commission (the SEC) on July 3, 2007, to disclose the appointment of Burton G. Malkiel, Ph.D. to the Aud...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support